Chemical Compound
(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxycamptothecin; (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 11-Ethyl-9-hydroxycamptothecin; Irinotecan Related Compound B; Irinotecan Hydrochloride Trihydrate Impurity E; Irinotecan Impurity E
CAS Registry Number
86639-52-3
Primary record
(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxycamptothecin; (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 11-Ethyl-9-hydroxycamptothecin; Irinotecan Related Compound B; Irinotecan Hydrochloride Trihydrate Impurity E; Irinotecan Impurity E
- 库存
- 2,578 克
- 纯度
- 99.3 %
- CAS
- 86639-52-3
化合物标识与属性
- CAS
- 86639-52-3
- PubChem CID
- 104842
- SMILES
- CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O
- Canonical SMILES
- CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
名称与同义词
- 7-Ethyl-10-hydroxycamptothecin
- SN-38
- 86639-52-3
- SN 38 lactone
- SN 38
- Camptothecin analog
- Deruxtecan analog
- 7-Ethyl-10-hydroxy-camptothecin
- 10-Hydroxy-7-ethylcamptothecin
- EHCPT
- HCPT
- Irinotecan related compound b
- SN38
- AvaChem1025
- SN-38 (Standard)
- LE-SN38
- MFCD00871873
- NK-012
- AC1L2XLK
- RefChem:914300
- 7-10-hydroxycamptothecin
- NK012
- NK 012
- 7-Ethyl-10-hydroxycamptothecine
- CHEMBL837
- D0B6YB
- D0L5LG
- diethyl(dihydroxy)[?]dione
- 7-Ethyl-10-hydroxy-20(S)-camptothecin
- CHEBI:8988
- C22H20N2O5
- SCHEMBL34018
- Captothecin, 7-ethyl-10-hydroxy-
- DTXSID4040399
- UNII-0H43101T0J
- 7-Ethyl-10-hydroxy camptothecin
- CHEMBL93068
- FJHBVJOVLFPMQE-QFIPXVFZSA-N
- GTPL6925
- orb1307686
- SN 38 [WHO-DD]
- SN-38L
- (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 7 Ethyl 10 hydroxycamptothecin
- 0H43101T0J
- DTXCID2020399
- SCHEMBL29354078
- SCHEMBL29359781
- SN-38-d3
- 10-hydroxy-7-ethyl camptothecin
- 10-hydroxy-7-ethyl-camptothecin
- KS-00000NHR
- 7-Ethyl-10-hydroxy campthotecin
- EX-A989
- IT-141
- NSC673596
- BADC-01393
- HMS3413B12
- HMS3652P12
- HMS3677B12
- HMS3753E15
- AOB33769
- BCP01386
- ZINC4099013
- 7-Ethyl-10-hydroxy-20(S)-CPT
- CAMPTOTHECIN, 7-ETHYL-10-HYDROXY-
- (R)-SN-38
- BDBM50418088
- CE-042
- CID104842
- EBC-11025
- HY-13704R
- Irinotecan EP Impurity E (SN-38)
- MSK162382
- s4908
- AKOS015920433
- C22-H20-N2-O5
- AC-1357
- ACN-035263
- ACN-054099
- AN-5834
- BCP9000200
- CB10641
- CCG-264764
- CS-1579
- CS-O-30862
- DB05482
- FE29579
- LS00055
- NSC-673596
- RL05364
- SN-38(NK-012)?
- (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN
- NCGC00167831-01
- NCGC00167831-05
- SN-38(7-Ethyl-10-hydroxycamptothecin)
- AJ-48031
- AK-36613
- AS-13533
- BC206169
- BP-24513
- BR-36613
- Camptothecin 7-Ethyl-10-Hydroxy Impurity
- HY-13704
- I605
- NCI60_026056
- SC-15667
- SY013197
- 7-Ethyl-10-Hydroxycamptothecin, food grade
- AB0013784
- J353.490A
- LS-127394
- TL8005626
- E0748
- FT-0630943
- FT-0674607
- FT-0674608
- N2133
- NS00069821
- SW219948-1
- S-(+)-7-ETHYL-10-HYDROXYCAMPOTHECIN
- A12011
- C11173
- EN300-122379
- IRINOTECAN RELATED COMPOUND B [USP-RS]
- J90015
- S-5119
- (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
- 439E812
- A857464
- F046379
- 113015-38-6
- A1010140
- Q1750127
- 50P114089
- BRD-K89561498-001-01-7
- BRD-K89561498-001-02-5
- (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
- (4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 7-Ethyl-10-hydroxycamptothecin, >=98% (HPLC), powder
- 7-Ethyl-10-hydroxycamptothecin, 99% - 100MG 100mg
- Z1541759909
- (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione
- Irinotecan EP Impurity E; Camptothecin 7-Ethyl-10-Hydroxy Impurity
- (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (1S,2S,3R)-1-(3,4-dihydroxy-5-methoxy-phenyl)-2,3,7-trihydroxy-3-(hydroxymethyl)-6-methoxy-tetralin-2-carboxylic acid
- 110714-48-2
- 1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4,11-DIETHYL-4,9-DIHYDROXY-, (4S)-
- H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (S)-
- Irinotecan Related Compound B, United States Pharmacopeia (USP) Reference Standard
- (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, AldrichCPR
- (4S)-4,11-Diethyl-4,9-dihydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- (4S)-4,9-Dihydroxy-4,11-diethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4,9-Dihydroxy-4alpha,11-diethyl-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- (4S)-4beta,9-Dihydroxy-4,11-diethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4beta,9-Dihydroxy-4,11-diethyl-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- (4S)-9-Hydroxy-4-hydroxy-4,11-diethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (5S)-3,2-(6-Hydroxy-4-ethylquinoline-2,3-diylmethylene)-5-hydroxy-5-ethyl-1,6(2H,8H)-dioxo-7-oxaisoquinoline
- (5S)-3,2-(6-Hydroxy-4-ethylquinoline-2,3-diylmethylene)-5alpha-hydroxy-5-ethyl-1,6(2H,8H)-dioxo-7-oxaisoquinoline
- (S)-4,11-Diethyl-4,9-di-OH-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- (S)-4,11-diethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
- (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxycamptothecin; (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 11-Ethyl-9-hydroxycamptothecin; Irinotecan Related Compound B; Irinotecan Hydrochloride Trihydrate Impurity E; Irinotecan Impurity E
- 119577-28-5
- 130144-34-2
- 130194-92-2
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,7-diethyl-4,10-dihydroxy-
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-
- 1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-
- 64439-81-2
- 647852-82-2
- 7-Ethyl-10-hydroxycamptothecin ((S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
- 718612-49-8
- EHC
- RS4